BIFIDO Co., Ltd. (KOSDAQ:238200)
3,330.00
-20.00 (-0.60%)
Last updated: Nov 18, 2025, 1:12 PM KST
BIFIDO Company Description
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally.
It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems.
The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
BIFIDO Co., Ltd.
| Country | South Korea |
| Founded | 1999 |
| Industry | Pharmaceutical Preparations |
| Employees | 83 |
Contact Details
Address: 23-16 Nonggongdanji-gil Hongcheon-eup South Korea | |
| Phone | 82 3 3435 4962 |
| Website | bifido.com |
Stock Details
| Ticker Symbol | 238200 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |